Head and neck cancer impacts vital functions; early diagnosis is crucial due to low awareness and varied symptoms. Seek ...

Abbreviations: BS, brainstem injury; CN, cranial nerve injury; NR, not reported; OP, optice nerve or chiasm injury; OS, overall survival; TLN, temporal lobe necrosis. Randomized study; percentage is ...

Fig 1. Study profile for the time-of-day patterns of radiotherapy in nasopharyngeal carcinoma. IMRT, intensity-modulated radiotherapy; NPC, nasopharyngeal carcinoma. More than 95% of patients, ...

So, I had radiation but it's come back with a vengeance. Now, they are calling it nasopharyngeal squamous cell carcinoma." According to the Mayo Clinic, nasopharyngeal carcinoma is a type of ...

Tevimbra is under clinical development by BeiGene and currently in Phase III for Nasopharyngeal Cancer. According to GlobalData, Phase III drugs for Nasopharyngeal Cancer have a 67% phase transition ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) said that it has launched Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.

Cash-strapped Viracta Therapeutics is continuing to reduce its options in order to stay afloat. Less than two months after ...

in India under the brand name Zytorvi for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC), a rare form of head and neck cancer. Loqtorzi, a novel anti-PD-1 ...

Considering taking supplements to treat nasopharyngeal cancer? Below is a list of common natural remedies used to treat or reduce the symptoms of nasopharyngeal cancer. Follow the links to read ...

ALEC-04 is under clinical development by Alentis Therapeutics and currently in Phase II for Nasopharyngeal Cancer.